# Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers

> **NCT00796744** · PHASE2 · COMPLETED · sponsor: **US Biotest, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Foot Ulcer, Diabetic
- Diabetic Foot

## Interventions

- **DRUG:** NorLeu3-A(1-7) in a gel formulation

## Key facts

- **NCT ID:** NCT00796744
- **Lead sponsor:** US Biotest, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-12
- **Final completion:** 2011-05
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2012-09-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796744, "Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00796744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*